![Xiromed LLC Launches Estradiol Transdermal Gel 0.1% with a Competitive Generic Therapy (CGT) Designation Xiromed LLC Launches Estradiol Transdermal Gel 0.1% with a Competitive Generic Therapy (CGT) Designation](https://xiromed.com/usa/wp-content/uploads/sites/6/2022/10/Estradiol_Family_Final_800x600-copy-1.png)
Xiromed LLC Launches Estradiol Transdermal Gel 0.1% with a Competitive Generic Therapy (CGT) Designation
![These highlights do not include all the information needed to use DIVIGEL safely and effectively. See full prescribing information for DIVIGEL. DIVIGEL ® (estradiol gel), for topical use Initial U.S. Approval: 1975 These highlights do not include all the information needed to use DIVIGEL safely and effectively. See full prescribing information for DIVIGEL. DIVIGEL ® (estradiol gel), for topical use Initial U.S. Approval: 1975](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=divigel-3.jpg&id=712718)
These highlights do not include all the information needed to use DIVIGEL safely and effectively. See full prescribing information for DIVIGEL. DIVIGEL ® (estradiol gel), for topical use Initial U.S. Approval: 1975
![Avion Pharmaceuticals recognizes Menopause Awareness Month by announcing the addition of Divigel® (estradiol gel) 0.1% to their product portfolio Avion Pharmaceuticals recognizes Menopause Awareness Month by announcing the addition of Divigel® (estradiol gel) 0.1% to their product portfolio](https://mma.prnewswire.com/media/1628835/21_DIV_4904_Bug_4C_1500px__3.jpg)